N@N

50.02% Of All NASDAQ Trading Wednesday Was Short Selling. PSEC, HILL, DVAX, RDCM, ELOS, DXCM Highest % Of Daily Trading Volume

^{Published on 2009-09-10 07:37:50, Last Modified on 2010-12-22 14:43:48 - WOPRAI}
 

September 10, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Wednesday, September 9th, 2009 and come to the following statistical conclusions. There were 6,676 stocks with daily short volume reported and total NASDAQ trading volume of 1,780,208,693 shares. Total Daily Short Volume was 890,564,581 shares. 50.02% of all trading on the NASDAQ Wednesday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Prospect Capital (NASDAQ: PSEC), Dot Hill Systems (NASDAQ: HILL), Dynavax Technologies (NASDAQ: DVAX), Radcom (NASDAQ: RDCM), Syneron Medical (NASDAQ: ELOS) and DexCom (NASDAQ: DXCM). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090909 PSEC 148,035 167,817 Q 88.21%

20090909 HILL 108,899 126,574 Q 86.04%

20090909 DVAX 87,906 106,049 Q 82.89%

20090909 RDCM 64,924 78,372 Q 82.84%

20090909 ELOS 541,763 662,050 Q 81.83%

20090909 DXCM 122,554 153,854 Q 79.66%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesai naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Prospect Capital Corporation (NASDAQ: PSEC) is a venture capital and private equity investment firm specializing in late venture, middle market, mature, mezzanine, buyouts, and bridge transactions. It makes secured debt and equity investments. The firm typically invests across all industry sectors, with a particular expertise in the energy and industrial sectors. It invests in oil and gas production, coal production, materials, industrials, consumer discretionary, information technology, utilities, pipeline, storage, power generation and distribution, renewable and clean energy, oilfield services, healthcare, food and beverage, education, and other select sectors. The firm prefers to invest in the United States and Canada. It seeks to invest between $5 million to $100 million in companies with EBITDA between $4 million and $75 million, sales value up to $500 million, and enterprise value of up to $250 million. The firm also co-invests for larger deals. Prospect Capital Corporation was founded in 1988 and is based in New York, New York.

Dot Hill Systems Corp. (NASDAQ: HILL) provides entry-level and midrange storage systems and enterprise server software for organizations requiring networked storage and data management solutions in open systems architecture. The companyais storage solutions consist of integrated hardware, firmware, and software products employing a modular system that allows end-users to add capacity as needed. Its product lines range from approximately 146 gigabyte to complete 108 terabyte storage systems. The company offers storage systems in fibre channel, Internet small computer systems interface, small computer systems interface (SCSI), serial attached SCSI, and serial ATA technologies with direct attached storage and storage area networks configurations. It also provides software that consists of storage management applications, performance enhancing software, data management services, and Web-based graphical user interface. Dot Hill Systems offers its products through channel partners, including original equipment manufacturers, systems integrators, distributors, and value added resellers. The company was founded in 1988 and is headquartered in Carlsbad, California.

Dynavax Technologies Corporation (NASDAQ: DVAX), a clinical-stage biopharmaceutical company, discovers and develops a diversified pipeline of Toll-like Receptor (TLR) product candidates primarily in the United States. Based on Dynavaxais proprietary technology platform, these products specifically modify the innate immune response to infectious, respiratory, autoimmune, and inflammatory diseases. The companyais product programs are supported by global partnerships with pharmaceutical companies, such as GlaxoSmithKline, AstraZeneca AB, and Novartis Vaccines and Diagnostics, Inc, as well as funding from Symphony Dynamo, Inc. and the National Institutes of Health (NIH). Its product candidates include HEPLISAV, a Phase 3 clinical stage product for the treatment of hepatitis B vaccine; SD-101, a Phase 1b clinical stage product for the treatment of Hepatitis C infection; and DV-601, a Phase 1b clinical stage product for the treatment of Hepatitis B infection. Dynavax Technologies Corporationais preclinical stage products include Universal Flu vaccine for the treatment of influenza prevention, AZD1419 for the treatment of asthma, and DV1079 for the treatment of autoimmune and inflammatory diseases. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.

Radcom Ltd. (NASDAQ: RDCM) engages in developing, manufacturing, marketing, and supporting network test and service monitoring solutions for communications service providers and equipment vendors worldwide. The companyais solutions include Omni-Q, a network testing, monitoring, and performance management solution that consists of a central management module, and a range of intrusive and non-intrusive probes used to gather transmission quality data from various types of networks and services, including universal mobile telecommunications service, code division multiple access, Internet protocol (IP) multimedia subsystem data, video voice over IP (VoIP), IP television, and others. Its solutions also comprise network protocol analyzers, which offer network testing, troubleshooting, and analysis solutions for cellular, VoIP, and data communications operators. The companyais solutions are used primarily for facilitating the maintenance of operational networks, as well as development and installation of network equipment; and facilitating fault management, network service performance monitoring and analysis, troubleshooting, and pre-mediation, as well as to collect network information for a third-party application. It serves telecommunications service providers, labs of telecommunication service providers, and data communications and telecommunications equipment developers and manufacturers. The company sells products directly, as well as through a network of independent distributors who market data communications-related hardware and software products. Radcom Ltd. was founded in 1985 and is based in Tel Aviv, Israel.

Syneron Medical Ltd. (NASDAQ: ELOS) designs, develops, and markets aesthetic medical products. The company develops products based on its proprietary ELOS technology, which combines conducted radiofrequency energy, an electrical energy; and light or laser-based energy, an optical energy. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skinais appearance, acne treatment, leg veins treatment, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, skin tightening, laser-assisted lipolysis, and dental laser. The company sells its products primarily to physicians and other practitioners, including plastic surgeons, aestheticians, medical spas, dentists, dermatologists, and cosmetic physicians. Syneron Medical Ltd. sells its products through a direct sales force in the United States and Canada, and through distributors in Europe, the Middle East, South Africa, the Asia-Pacific region, and South and Central America. The company was founded in 2000 and is headquartered in Yokneam Illit, Israel.

DexCom, Inc. (NASDAQ: DXCM), a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. The company was founded in 1999 and is headquartered in San Diego, California.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each monthais short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net